Recombinant Adenoviral Gene Transfer Does Not Affect Cardiac Allograft Vasculopathy

Vinay P. Rao, Stefano E. Branzoli, Davide Ricci, Naoto Miyagi, Timothy O'Brien, Henry D. Tazelaar, Stephen J. Russell, Christopher G.A. McGregor

Research output: Contribution to journalArticle

2 Scopus citations

Abstract

Background: Adenovirus serotype 5 has remained the pre-eminent vector in pre-clinical gene therapy applications in cardiac transplantation. Concerns over the potential effects of adenoviral vectors on the later development of cardiac allograft vasculopathy (CAV) are addressed in this study. Methods: Hearts (n = 22) harvested from Brown Norway rats were perfused ex vivo with either University of Wisconsin (UW) solution with no virus, Ad-CMV-LacZ or Ad-CMV-Null. Donor hearts were transplanted heterotopically into the abdomen of Lewis rats. All recipients received cyclosporine for the duration of the experiment. Transplanted hearts were recovered for analysis at 120 days. Sections of the heart were stained with elastic-van Gieson stain for morphometric analysis of the vessels to ascertain the degree of vascular luminal occlusion. Hematoxylin-eosin staining facilitated diagnosis of chronic rejection. Results: Seventy-seven percent of transplanted hearts showed signs of chronic rejection with no difference in the proportion of animals between groups (p = 0.797). No difference was noted in the degree of vascular luminal occlusion between the Ad-Null (0.57 ± 0.22), Ad-LacZ (0.62 ± 0.19) and UW (0.47 ± 0.29) groups (p = 0.653). Conclusions: Vascularized cardiac allografts transplanted from Brown Norway to Lewis rats demonstrated cardiac allograft vasculopathy CAV at 120 days. Adenoviral perfusion of the donor heart ex vivo did not affect the development of CAV.

Original languageEnglish (US)
Pages (from-to)1281-1285
Number of pages5
JournalJournal of Heart and Lung Transplantation
Volume26
Issue number12
DOIs
StatePublished - Dec 2007

ASJC Scopus subject areas

  • Surgery
  • Pulmonary and Respiratory Medicine
  • Cardiology and Cardiovascular Medicine
  • Transplantation

Fingerprint Dive into the research topics of 'Recombinant Adenoviral Gene Transfer Does Not Affect Cardiac Allograft Vasculopathy'. Together they form a unique fingerprint.

  • Cite this

    Rao, V. P., Branzoli, S. E., Ricci, D., Miyagi, N., O'Brien, T., Tazelaar, H. D., Russell, S. J., & McGregor, C. G. A. (2007). Recombinant Adenoviral Gene Transfer Does Not Affect Cardiac Allograft Vasculopathy. Journal of Heart and Lung Transplantation, 26(12), 1281-1285. https://doi.org/10.1016/j.healun.2007.09.018